Mohamed Aburawi joined HC in 2004 and currently heads the coverage of : F&B, FMCG, Pharma, Healthcare, White Goods, Automotive, Textiles and TMT industry clusters. Over his 16-years of investment banking experience, Mohamed has a deal execution track record of M&A, capital & debt raising and divestitures transactions, valued in excess of USD1.8Bn advising some of the most prominent corporates. His representative transactions include (1) advising Hikma Pharmaceuticals on the acquisition of 100% of EIMC United Pharmaceuticals, (2) Coca-Cola Bottling Company of Egypt on arranging a syndicated loan facility, (3) Middle East Glass Company on its 100% acquisition of Wadi Glass Containers, (4) Tabuk Pharmaceuticals on their 100% acquisition of Alpha Pharmaceuticals, (5) Guemei Family on the sale of 51% of ASEC Group to Citadel Capital, (6) Emirates NBD on the acquisition of BNP Paribas Le Caire, (7) MobiTel Iraq on the 3G license project, (8) Fiancée brand on the sale of 100% of the company to Marico, (9) Ripplewood on the acquisition of 18.7% of Commercial International Bank, (10) ITWorx on the divestiture of 79%, and (11) Almarai on the acquisition of International Company for Agro-Industrial Projects (Beyti).
Mohamed holds a MSc in international securities and investment banking from the University of Reading (ISMA Centre), UK.
